Transcarent

Transcarent

On-demand medical access and delivery

Overview

Transcarent runs a digital health platform for individuals, families, and employers, offering 24/7 access to doctors via chat, personalized care guidance from health concierges, and doorstep medication delivery. Members join through employer plans or directly, then use the app or website to chat with doctors within 60 seconds, receive tailored care help, and order medicines to be shipped to their home. It differentiates itself by pairing immediate medical access with concierge support and cost transparency, supported by subscription options for employers and premium plans for individuals. The goal is to make healthcare less confusing, simpler to navigate, and more affordable by delivering easy access to care, trusted guidance, and clear information.

About Transcarent

Simplify's Rating
Why Transcarent is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Consumer Software

Enterprise Software

Healthcare

Company Size

501-1,000

Company Stage

Series D

Total Funding

$424M

Headquarters

San Francisco, California

Founded

2020

Your Connections

People at Transcarent who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • SmithRx partnership enables real-time prescription cost intelligence with average savings exceeding 20%.
  • Bluespine partnership integrates AI-powered payment integrity to detect 100% of claims instead of samples.
  • Anjali Jameson leads agentic AI platform that anticipates patient needs and books appointments automatically.

What critics are saying

  • Accolade integration failure dilutes navigation value post-$621M acquisition within 12–18 months.
  • SmithRx partnership enables employers to bypass Transcarent for standalone pharmacy cost intelligence in 6–12 months.
  • 98point6 AI virtual care platform shuts down due to regulatory scrutiny on AI diagnostic accuracy within 18–30 months.

What makes Transcarent unique

  • Transcarent is the sole generative AI-powered personalized health platform on the market.
  • Members chat with a doctor within 60 seconds, 24/7, at no cost.
  • Transcarent directly contracts rates upfront with health systems for competitive pricing nationwide.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$424M

Above

Industry Average

Funded Over

4 Rounds

Series D funding is typically for companies that are already well-established but need more funding to continue their growth. This round is often used to stabilize the company or prepare for an IPO.
Series D Funding Comparison
Above Average

Industry standards

$77M
$70M
Twilio
$80M
Handshake
$100M
Affirm
$126M
Transcarent

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Unlimited Paid Time Off

Paid Vacation

Mental Health Support

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

-3%

2 year growth

-3%
Business Wire
Mar 17th, 2026
Transcarent partners with Bluespine to tackle $300B healthcare fraud with AI-powered payment integrity

Transcarent has launched a payment integrity category in its Experience Store through a partnership with Bluespine, an AI-driven health technology company. The initiative aims to help self-insured employers detect overbilling and reduce waste in healthcare spending. Fraud, waste and abuse account for an estimated 3% to 10% of total US healthcare spending, representing over $300 billion annually. Unlike traditional audits that review limited claim samples, Bluespine analyses 100% of medical and pharmacy claims using AI to identify overpayments, policy violations and billing errors. The platform supports both prepayment review and post-payment recovery, validating claims against employers' specific plan documents, coverage exclusions and negotiated rates. Every identified issue is documented with clear evidence tied to plan language or billing guidelines, enabling streamlined recovery without disrupting member experience.

Business Wire
Jan 9th, 2025
Transcarent To Acquire Accolade

Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care, an

FinSMEs
May 2nd, 2024
Transcarent Raises $126M in Series D Funding

Transcarent, a San Francisco, CA-based healthcare platform provider, raised $126m in Series D funding

Business Wire
Mar 8th, 2023
Transcarent to Acquire 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care announced plans to acquire the

FinSMEs
Jan 11th, 2022
Transcarent Raises $200M in Series C Funding

Transcarent, a Palo Alto, Calif.-based health and care experience company, raised $200m in Series C funding

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Transcarent right now.

Find jobs on Simplify and start your career today

We update Transcarent's jobs every few hours, so check again soon! Browse all jobs →